JMB

eISSN 1738-8872
pISSN 1017-7825

Table. 2.

Table. 2.

Approved vaccines to prevent MPXV infection.

Trade name Manufacturer Molecule type Target disease Inoculation site Dosing interval and number Injection volume Side effects
JYNNEOS/ Imvanex Bavarian
Nordic AS
Live
Attenuated
Vaccine
Monkeypox; smallpox; vaccinia virus (EU only) Subcutaneous
Intradermal
2 doses administered 28 days (4 weeks) apart 0.5 ml
0.1 ml
Pain at the injection site, redness, itching, fever, headache, tiredness, nausea, chills, and muscle aches
ACAM2000 Gaithersburg, Inc. Live virus
Vaccine
Smallpox Percutaneous Single dose using a bifurcated needle 0.0025 ml droplet of reconstituted vaccine (100 doses) Itching, sore arm, fever, headache, body ache, mild rash, fatigue, myocarditis, and pericarditis
J. Microbiol. Biotechnol. 2023;33:981~991 https://doi.org/10.4014/jmb.2306.06033
© J. Microbiol. Biotechnol.